Market Overview

ACADIA Pharma Shares Move Higher as JMP Boosted Price Target from $16 to $27

Related ACAD
Benzinga's Top Initiations
Cowen & Company Initiates ACADIA Pharmaceuticals At Outperform

JMP Securities maintains ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) with a Market Outperform and raises the price target from $16.00 to $27.00.

The stock has opened up more than 4 percent higher. With the stock last trading at $19.45, the firm's new price target implies potential upside of about 39 percent.

Latest Ratings for ACAD

DateFirmActionFromTo
Nov 2014Cowen & CompanyInitiates Coverage onOutperform
May 2014JP MorganInitiates Coverage onOverweight
Aug 2013McNicoll Lewis VlakDowngradesBuyHold

View More Analyst Ratings for ACAD
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (ACAD)

Around the Web, We're Loving...

Get Benzinga's Newsletters